(E)-Tamoxifen

CAS : 13002-65-8

Ref. 3D-FT27995

Informations sur le produit

• Nom: (E)-Tamoxifen
• Synonymes: 2-[4-[(1E)-1,2-Diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-ethanamine2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-ethylamine cis-Tamoxifen, 2-[4-[(1E)-1,2-Diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethylethanamine, Brn 2062021, Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (E)-, Ethanamine, 2-[4-[(1E)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, Ethanamine, 2-[4-[(1E)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, Ethylamine, 2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (E)-, Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (E)-, Tamoxifen (E), cis-Tamoxifen

Description

Tamoxifen is a drug that belongs to the group of antiestrogens. It is used in cancer treatment and is administered orally, intravenously, or by intramuscular injection. Tamoxifen has been shown to bind to estrogen receptors and inhibit the growth of estrogen-dependent breast cancer cells. Tamoxifen also has a number of metabolites, which are formed through reactions with reactive functional groups such as hydroxyl and cyano groups. These metabolites can be detected using magnetic resonance spectroscopy (MRS) and nuclear magnetic resonance (NMR). Some of these metabolites have been shown to have an effect on cell nuclei, including binding to DNA or altering the activity of enzymes involved in DNA synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 371.52 g/mol
• Formule: C₂₆H₂₉NO
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder
• InChI: InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25+
• Code InChI: InChIKey=NKANXQFJJICGDU-OCEACIFDSA-N
• SMILES: CC/C(=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1